To assess whether the same metabolic rewiring occurs in aortas from MFS patients (Figure 3A), we measured TFAM mRNA and mtDNA levels and the expression of mitochondrial function genes in TAAs from MFS patients. The gene discussed is TFAM; the disease is Marfan syndrome.